Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Unknown 9Completed 6Recruiting 4Not yet recruiting 3Terminated 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 4Esophageal Squamous Cell Carcinoma 4Pancreatic Neoplasms 1Malignant Neoplasms of Digestive Organs 1Gastric Adenocarcinoma 1Fruquintinib 1Esophageal Neoplasms 1

Interventions

Oxaliplatin 42Fluorouracil 27Capecitabine 24pembrolizumab 21S 1 (combination) 19Paclitaxel 19Leucovorin 16Nivolumab 13sintilimab 12Drug Therapy 12Docetaxel 12tislelizumab 11Trastuzumab 10Cisplatin 10Irinotecan 8Bevacizumab 8trastuzumab deruxtecan 7spartalizumab 7fludarabine 7XELOX 7Surgical Procedures, Operative 7Radiotherapy 7Cyclophosphamide 7Biopsy 7disitamab vedotin 6Hyperthermic Intraperitoneal Chemotherapy 6lenvatinib 5apatinib 5Specimen Handling 5Ramucirumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Stomach Neoplasms × Tegafur × Clear all
NCT07007182 2026-05-01

Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer

Shandong Cancer Hospital and Institute

Phase 2 Recruiting
54 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06461910 2026-03-03

Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Stomach Neoplasms

NCT07165847 2025-09-10

Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase 2 Recruiting
40 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03941561 2019-05-31

S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC)

Fudan University

Phase 3 Recruiting
1,006 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡